Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models

Summary

Tonix Pharmaceuticals published peer-reviewed research in the Journal of Virology showing that the 2022 mpox outbreak strain (clade IIb) is 100 to 100,000-fold less virulent than the 2003 outbreak strain (clade IIa) using new animal models.